GEN Editorial and Scientific Advisory Board

  • Peter Banks, Ph.D.
    Scientific Director, BiotTek Instruments
  • Roslyn (Brandon) Hendriks, D.V.M.
    Managing Partner at C-Suite Corporate, The University of Queensland
  • Robert Clarke, Ph.D.
    President & CEO, Pulmatrix
  • Pete Gagnon
    Chief Scientific Officer, BIA Separations
  • Uwe Gottschalk, Ph.D.
    Chief Scientific Officer, Lonza
  • Harry E. Gruber, M.D.
    CEO, Tocagen: Jin Seok Hur, Ph.D., Technology Director, Novasep
  • James Inglese, Ph.D.
    Investigator at National Center for Advancing Translational Sciences
  • Guenter Jagschies
    Senior Director, GE Healthcare Life Sciences
  • Peter Johnson, M.D.
    Principal, MedisurgePI
  • Anis H. Khimani, Ph.D.
    Head of Strategy and Marketing, Research Reagent Solutions, PerkinElmer
  • Mikael Kubista, Ph.D.
    CEO and Founder, TATAA Biocenter
  • Peter Levison
    Senior Marketing Director, Downstream Processing, Pall Life Sciences
  • Jan Lichtenberg, Ph.D.
    CEO and Co-Founder, InSphero
  • Miodrag MIcic, Sc.D., Ph.D.
    Professor and Department Chairman, Cerritos College
  • Eric Schadt, Ph.D.
    Icahn School of Medicine at Mount Sinai-Professor/Dean, Precision Medicine
    Founding Director, Icahn Institute for Genomics & Multiscale Biology
    Chair, Department of Genetics and Genomic Sciences
    Founder, Sema4
  • Zhiwei Song, Ph.D.
    Scientist, National University of Singapore
  • Sumio Sugano, M.D., Ph.D.
    Professor, Medical Genomics, University of Tokyo
  • John Talley, Ph.D.
    Medicinal Chemist, Euclises Pharmaceuticals
  • Bin Wang, Ph.D., Professor
    Principal Investigator, Fudan University Medical College
  • Daniel Wang, Ph.D.
    Institute Professor of Chemical Engineering, MIT